This loss of GN expression results from mutant APC-β-catenin-TCF transcriptional regulation, which suppresses GC-C signaling and perturbs intestinal homeostatic mechanisms, contributing to tumor progression. The gene discussed is HNF4A; the disease is neoplasm.